8/26/2013

Abbott has completed its purchase of IDEV Technologies for $310 million. The acquisition includes IDEV's Supera Veritas system, a self-expanding stent designed to treat patients with peripheral artery disease. The device already is available commercially in Europe, but is still undergoing FDA premarket review.

Related Summaries